首页 | 本学科首页   官方微博 | 高级检索  
检索        


Management guidelines for uninvestigated and functional dyspepsia in the Asia-Pacific region: First Asian Pacific working party on functional dyspepsia
Authors:NICHOLAS J TALLEY    SK LAM  KL GOH  KM FOCK
Institution:Department of Medicine, University of Sydney, Nepean Hospital, New South Wales, Australia;*University of Hong Kong, Queen Mary Hospital, Hong Kong;?University of Malaya and the University Hospital, Kuala Lumpur, Malaysia;?Faculty of Medicine, University of Singapore and New Changi Hospital, Singapore
Abstract:Dyspepsia is most optimally defined as pain or discomfort centred in the upper abdomen. The symptom complex may be caused by peptic ulcer disease, gastro-oesophageal reflux, or gastric cancer but is most often due to functional (or non-ulcer) dyspepsia. While upper endoscopy is the method of choice to determine the underlying cause of dyspepsia, it is expensive. A more pragmatic approach is needed in the Asia-Pacific region where health services are limited. A detailed treatment algorithm is given for managing patients presenting with new-onset dyspepsia and documented functional dyspepsia after endoscopy, and evidence to support this approach is reviewed. Prompt endoscopy is recommended for patients with alarm features. In patients without alarm features, treatment for 2–4 weeks with an empirical anti-secretory or prokinetic agent, followed by investigation using non-invasive Helicobacter pylori testing and treatment for patients who do not respond or relapse, is recommended. Trials of management strategies are now needed to establish the efficacy and cost-effectiveness of the approaches recommended.
Keywords:antisecretory cisapride    domperidone    endoscopy    functional dyspepsia    H2 blocker                H  pylori    management trials    non-ulcer dyspepsia    prokinetic    proton pump inhibitor  
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号